Visum Therapeutics
Develops small molecule y p p g therapeutic to treat Stargardt&s;s disease,
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Visum Therapeutics Information
Geographic Data
Address:
City: Cleveland
State: Ohio
Zip:
Country: United States
Financial Info
Stage:
seed
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Visum Therapeutics develops small molecule y p p g therapeutic to treat Stargardt&s;s disease, a degenerative condition that leads to blindness and is the most common form of inherited juvenile macular degeneration. Much of the pathology of Stargardt&s;s disease is shared with the more common Age-related Macular Degeneration (AMD).
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2010 | Seed Round | 1 | - |
Case Technology Ventures Case Technology Ventures |
12/2010 | Seed Round | 1 | - |
Case Technology Ventures Case Technology Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
